Comparison of parameters of 123I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: Correlation with clinical features

Annals of Nuclear Medicine

Volumn 25, Issue 7, 2011, Pages 478-485

  Uchiyama, Yumiko ^a   Momose, Mitsuru ^a   Kondo, Chisato ^a   Kusakabe, Kiyoko ^a   Uchiyama, Shinichiro ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Autonomic nervous system; Heart to mediastinum ratio; Lewy body disease; Parkinson's syndrome

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BRADYKINESIA; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; FEMALE; FOLLOW UP; HALLUCINATION; HEART; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RIGIDITY; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TREMOR;

EID: 85027931412     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-011-0490-2     Document Type: Article

References (41)

1. IG McKeith 2000 Clinical Lewy body syndromes Ann N Y Acad Sci 920 1 8 11193136 10.1111/j.1749-6632.2000.tb06898.x 1:STN:280:DC%2BD3M7gslWitg%3D%3D (Pubitemid 32056545)
2. WR Gibb AJ Lees 1988 The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease J Neurol Neurosurg Psychiatry 51 745 752 2841426 10.1136/jnnp.51.6.745 1:STN:280:DyaL1czgtVSqsg%3D%3D
3. DB Calne BJ Snow C Lee 1992 Criteria for diagnosing Parkinson's disease Ann Neurol 32 Suppl S125 S127 1510370 10.1002/ana.410320721
4. AJ Hughes SE Daniel AJ Lees 2001 Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease Neurology 57 1497 1499 11673599 1:STN:280:DC%2BD3MrmslCltA%3D%3D (Pubitemid 32995738)
5. H Sawada T Oeda K Yamamoto N Kitagawa E Mizuta R Hosokawa, et al. 2009 Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease Eur J Neurol 16 174 182 19146639 10.1111/j.1468-1331.2008.02372.x 1:STN:280:DC%2BD1M%2FnsVyjuw%3D%3D
6. H Nagayama M Hamamoto M Ueda J Nagashima Y Katayama 2005 Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease J Neurol Neurosurg Psychiatry 76 249 251 15654042 10.1136/jnnp.2004.037028 1:STN:280:DC%2BD2M%2FislSrtw%3D%3D (Pubitemid 40143717)
7. KR Chaudhuri DG Healy AH Schapira Excellence NIfC 2006 Non-motor symptoms of Parkinson's disease: diagnosis and management Lancet Neurol 5 235 245 16488379 10.1016/S1474-4422(06)70373-8 (Pubitemid 43238347)
8. M Yoshita 1998 Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy J Neurol Sci 155 60 67 9562324 10.1016/S0022-510X(97)00278-5 1:STN:280:DyaK1c3itVOqsQ%3D%3D (Pubitemid 28141060)
9. J Taki M Yoshita M Yamada N Tonami 2004 Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease Ann Nucl Med 18 453 461 15515743 10.1007/BF02984560 (Pubitemid 39410243)
10. A Druschky MJ Hilz G Platsch M Radespiel-Troger K Druschky T Kuwert, et al. 2000 Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT J Neurol Sci 175 3 12 10785250 10.1016/S0022-510X(00)00279-3 1:STN:280:DC%2BD3c3kslegtA%3D%3D (Pubitemid 30227477)
11. S Braune M Reinhardt R Schnitzer A Riedel CH Lucking 1999 Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy Neurology 53 1020 1025 10496261 1:STN:280:DyaK1MvisVGrsg%3D%3D (Pubitemid 29442118)
12. S Hakusui T Yasuda T Yanagi J Tohyama Y Hasegawa Y Koike, et al. 1994 A radiological analysis of heart sympathetic functions with meta-[123I] iodobenzylguanidine in neurological patients with autonomic failure J Auton Nerv Syst 49 81 84 7963268 10.1016/0165-1838(94)90023-X 1:STN:280: DyaK2M%2Flt1ehsA%3D%3D (Pubitemid 24230274)
13. S Orimo E Ozawa S Nakade T Sugimoto H Mizusawa 1999 (123)I- metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease J Neurol Neurosurg Psychiatry 67 189 194 10406987 10.1136/jnnp.67.2.189 1:STN:280:DyaK1MzjslOmtg%3D%3D (Pubitemid 29326950)
14. J Taki K Nakajima EH Hwang I Matsunari K Komai M Yoshita, et al. 2000 Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u. ac.jp Eur J Nucl Med 27 566 573 10853813 10.1007/s002590050544 1:STN:280:DC%2BD3cvjs1ansg%3D%3D (Pubitemid 30262623)
15. H Takatsu H Nishida H Matsuo S Watanabe K Nagashima H Wada, et al. 2000 Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG J Nucl Med 41 71 77 10647607 1:STN:280:DC%2BD3c7ht1WgsQ%3D%3D (Pubitemid 30046686)
16. S Orimo T Uchihara A Nakamura F Mori A Kakita K Wakabayashi, et al. 2008 Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease Brain 131 642 650 18079166 10.1093/brain/awm302 (Pubitemid 351294710)
17. H Takano N Yoshimura 1993 Markedly decreased cardiac uptake with 123I-MIBG scintigraphy in a case of pure progressive autonomic failure Rinsho Shinkeigaku 33 784 786 8252835 1:STN:280:DyaK2c%2FnsVamtw%3D%3D (Pubitemid 24000395)
18. H Watanabe T Ieda T Katayama A Takeda I Aiba M Doyu, et al. 2001 Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease J Neurol Neurosurg Psychiatry 70 781 783 11385013 10.1136/jnnp.70.6.781 1:STN:280:DC%2BD3Mzht1SjsQ%3D%3D (Pubitemid 32554209)
19. M Yoshita J Taki M Yamada 2001 A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies J Neurol Neurosurg Psychiatry 71 583 588 11606666 10.1136/jnnp.71.5.583 1:STN:280:DC%2BD3MrmtVyntQ%3D%3D (Pubitemid 33010570)
20. K Kashihara M Ohno S Kawada Y Okumura 2006 Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies J Nucl Med 47 1099 1101 16818943 1:CAS:528:DC%2BD28XnslSmtrs%3D (Pubitemid 47544904)
21. S Gilman PA Low N Quinn A Albanese Y Ben-Shlomo CJ Fowler, et al. 1999 Consensus statement on the diagnosis of multiple system atrophy J Neurol Sci 163 94 98 10223419 10.1016/S0022-510X(98)00304-9 1:STN:280:DyaK1M3jsl2gsg%3D%3D (Pubitemid 29155424)
22. AJ Hughes SE Daniel L Kilford AJ Lees 1992 Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 181 184 1564476 10.1136/jnnp.55.3.181 1:STN:280:DyaK383is1Omsg%3D%3D
23. I Litvan Y Agid D Calne G Campbell B Dubois RC Duvoisin, et al. 1996 Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop Neurology 47 1 9 8710059 1:STN:280:DyaK283ptFSjtA%3D%3D (Pubitemid 26243849)
24. IG McKeith DW Dickson J Lowe M Emre JT O'Brien H Feldman, et al. 2005 Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium Neurology 65 1863 1872 16237129 10.1212/01.wnl.0000187889.17253.b1 1:STN:280:DC%2BD2Mnpt1GqsQ%3D%3D (Pubitemid 43970103)
25. H Kobayashi M Momose S Kanaya C Kondo K Kusakabe N Mitsuhashi 2003 Scatter correction by two-window method standardizes cardiac I-123 MIBG uptake in various gamma camera systems Ann Nucl Med 17 309 313 12932115 10.1007/BF02988527 (Pubitemid 37012044)
26. M Momose H Kobayashi N Iguchi N Matsuda Y Sakomura H Kasanuki, et al. 1999 Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy Nucl Med Commun 20 529 535 10451865 10.1097/00006231-199906000-00007 1:STN:280:DyaK1MzotFWksA%3D%3D (Pubitemid 29509990)
27. DS Goldstein G Eisenhofer BB Dunn I Armando J Lenders E Grossman, et al. 1993 Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans J Am Coll Cardiol 22 1961 1971 8245356 10.1016/0735-1097(93)90786-Z 1:STN:280:DyaK2c%2FmsFSmsQ%3D%3D (Pubitemid 23359660)
28. ST Li R Dendi C Holmes DS Goldstein 2002 Progressive loss of cardiac sympathetic innervation in Parkinson's disease Ann Neurol 52 220 223 12210793 10.1002/ana.10236 (Pubitemid 34810603)
29. TR Degrado MR Zalutsky G Vaidyanathan 1995 Uptake mechanisms of meta-[123I]iodobenzylguanidine in isolated rat heart Nucl Med Biol 22 1 12 7735158 10.1016/0969-8051(94)00084-W 1:CAS:528:DyaK2MXkslGisbY%3D
30. O Schnell D Muhr M Weiss S Dresel M Haslbeck E Standl 1996 Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients Diabetes 45 801 805 8635656 10.2337/diabetes.45.6.801 1:CAS:528: DyaK28Xjs1OisrY%3D
31. K Sakata K Iida N Mochizuki M Ito Y Nakaya 2009 Physiological changes in human cardiac sympathetic innervation and activity assessed by (123)I-metaiodobenzylguanidine (MIGB) imaging Circ J 73 310 315 19057084 10.1253/circj.CJ-08-0614
32. S Nagamachi H Wakamatsu S Kiyohara S Fujita S Futami S Tamura, et al. 2008 Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy Ann Nucl Med 22 557 564 18756357 10.1007/s12149-008-0156-x
33. JC Zijlmans SE Daniel AJ Hughes T Revesz AJ Lees 2004 Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis Mov Disord 19 630 640 15197700 10.1002/mds.20083 (Pubitemid 39173015)
34. M Suzuki N Hattori S Orimo N Fukumitsu M Abo Y Kono, et al. 2005 Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report Mov Disord 20 634 636 15704207 10.1002/mds.20384 (Pubitemid 40862267)
35. A Quattrone A Bagnato G Annesi F Novellino L Morgante G Savettieri, et al. 2008 Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease Mov Disord 23 21 27 17975812 10.1002/mds.21701 (Pubitemid 351281213)
36. S Orimo T Amino M Yokochi T Kojo T Uchihara A Takahashi, et al. 2005 Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2 Mov Disord 20 1350 1353 16001409 10.1002/mds.20594 (Pubitemid 41645912)
37. JC Klein C Eggers E Kalbe S Weisenbach C Hohmann S Vollmar, et al. 2010 Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo Neurology 74 885 892 20181924 10.1212/WNL.0b013e3181d55f61 1:CAS:528:DC%2BC3cXltV2nu7g%3D
38. H Oka M Yoshioka M Morita K Onouchi M Suzuki Y Ito, et al. 2007 Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease Neurology 69 1460 1465 17909159 10.1212/01.wnl.0000277450.49788.82 1:STN:280:DC%2BD2srovVSrtw%3D%3D (Pubitemid 47511468)
39. GK Wenning C Scherfler R Granata S Bösch M Verny KR Chaudhuri, et al. 1999 Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study J Neurol Neurosurg Psychiatry 67 620 623 10519868 10.1136/jnnp.67.5.620 1:STN:280:DyaK1MvltFWgtQ%3D%3D (Pubitemid 29486210)
40. K Ishibashi Y Saito S Murayama K Kanemaru K Oda K Ishiwata, et al. 2010 Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET Eur J Nucl Med Mol Imaging 37 3 11 19626324 10.1007/s00259-009-1202-1
41. P Jokinen H Helenius E Rauhala A Bruck O Eskola JO Rinne 2009 Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls J Nucl Med 50 893 899 19443601 10.2967/jnumed.108.061572